Yahoo Web Search

Search results

  1. Biography. I am a pharmaceutical doctor and medical virologist at Institut Pasteur de Madagascar – belonging to Institut Pasteur International Network – involved in research and public health with specialized interest in diagnosis, epidemiology and molecular characterization of emerging tropical infectious diseases, mainly arboviral ...

  2. Dr Philippe Dussart is a medical virologist at the Institut Pasteur de Madagascar, part of the Institut Pasteur International Network. He is involved in research and public health with a special interest in the diagnosis, epidemiology and molecular characterization of emerging tropical infectious diseases, mainly arboviral diseases (dengue ...

  3. Philippe DUSSART, Head of Virology unit | Cited by 4,415 | of Institut Pasteur International Network, Paris | Read 276 publications | Contact Philippe DUSSART

  4. Nov 17, 2021 · Formed as biologist pharmacist and holder of a doctorate in microbiology, specialised in virology, Philippe Dussart has been working for the Pasteur Network for the 20 years in 3 different regions: Africa, Americas, Asia-Pacific.

    • Study Location
    • Study Population
    • Covariates Included, Data Collection and Statistical Analysis
    • Ethical Considerations

    French Guiana is a French Overseas territory located on the north-eastern coast of South America. About 90% of its surface of 84,000 km2 is Amazonian rain forest; the remaining 10% in the north is a coastal plain where 90% of the 215,000 inhabitants live and Cayenne and surroundings contain almost 50% of the population in 2009 . Malaria and dengue ...

    A matched retrospective study was conducted comparing patients infected with concurrent malaria and dengue to patients with either infection alone. The study population included all patients admitted in the emergency department of Cayenne hospital, between June 2004 and February 2010. The diagnosis of dengue and malaria co-infection was made on the...

    Patients’ data, including socio-epidemiologic data, previous medical history, clinical symptoms, and biological results, were obtained from the computerized medical charts. Data were analysed using R version 2.10.0® and the Epicalc® package. The continuous variables of interest were categorized following the laboratory cut-off values, or published ...

    The retrospective use of anonymous patient files on the site of patient care is authorized by the French National Commission on Informatics and Liberties. All the data collected retrospectively were anonymized in a standardized case report form and in the database.

  5. Abstract. Background: Dengue has emerged as the most important vector-borne viral disease in tropical areas. Evaluations of the burden and severity of dengue disease have been hindered by the frequent lack of laboratory confirmation and strong selection bias toward more severe cases.

  6. May 12, 2016 · Dengvaxia and dengue vaccine development is just one of the subjects addressed by Dr. Philippe Dussart, Head of the Virology Unit at the Institut Pasteur in Cambodia in an interview called "The Dengue Peril" by the Cambodian magazine Healthwise Digest (Vol. 2 No.12 March 2016). Dr.

  1. People also search for